Hamartoma: Clinical Trials

4 trials for Hamartoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown. 4 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Unknown 4
Phase 31Unknown 1

Follow Hamartoma: new trials by email Literature Review of Hamartoma trials Research Report on Hamartoma

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex
Aspirin, AED, Placebo - Tuberous Sclerosis Complex, Aspirin
Phase 2UnknownPeking Union Medical College Hospital982017-11-202020-06-09
Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex
Everolimus, Placebo - Tuberous Sclerosis Complex, TSC Related Cognitive Disability
Phase 2 / Phase 3UnknownErasmus Medical Center602012-11-012015-05-05
A Study of Everolimus in the Treatment of Neurocognitive Problems in Tuberous Sclerosis
Placebo, Everolimus (RAD001) - Tuberous Sclerosis
Phase 2UnknownCardiff University482012-06-012018-01-30
Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM
sirolimus - Tuberous Sclerosis, Lymphangioleiomyomatosis
Phase 2UnknownCardiff University142005-10-012008-04-30

Narrower conditions

Tuberous Sclerosis (4)  ·  Autistic Disorder (1)  ·  Cognitive Dysfunction (1)  ·  Epilepsy (1)  ·  Intellectual Disability (1)  ·  Lymphangioleiomyomatosis (1)  ·  Seizures (1)

Broader conditions

Congenital Abnormalities (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Genetic Diseases, Inborn (4)  ·  Heredodegenerative Disorders, Nervous System (4)  ·  Malformations of Cortical Development (4)  ·  Malformations of Cortical Development, Group I (4)  ·  Neoplasms (4)  ·  Neoplasms, Multiple Primary (4)  ·  Neoplastic Syndromes, Hereditary (4)  ·  Nervous System Diseases (4)  ·  Nervous System Malformations (4)  ·  Neurocutaneous Syndromes (4)  ·  Neurodegenerative Diseases (4)  ·  Mental Disorders (2)

Interventions

Everolimus (2)  ·  Anticonvulsants (1)  ·  Aspirin (1)  ·  Sirolimus (1)

Sponsors

Cardiff University (2)  ·  Erasmus Medical Center (1)  ·  Peking Union Medical College Hospital (1)

Countries

United Kingdom (2)  ·  China (1)  ·  Netherlands (1)

Top investigators

Julian R Sampson, DM (1)  ·  Julian Sampson, Prof (1)  ·  Qing Liu, MD PhD (1)

Results publications

PMID 21525172, PMID 31217257, PMID 42562625